ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide ; volume:12 ; number:1 ; day:3 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Scientific reports ; 12, Heft 1 (3.8.2022), 1-15, 12.2022

Creator: Raghava Kurup, Reshma
Oakes, Eimile K.
Vadlamani, Pranathi
Nwosu, Obi
Danthi, Pranav
Hundley, Heather A.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-022-17559-4

URN: urn:nbn:de:101:1-2022101322533964504972

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Raghava Kurup, Reshma
Oakes, Eimile K.
Vadlamani, Pranathi
Nwosu, Obi
Danthi, Pranav
Hundley, Heather A.
SpringerLink (Online service)

Other Objects (12)

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

$Accelerated hyperfractionation plus temozolomide in glioblastoma$

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

$Accelerated hyperfractionation plus temozolomide in glioblastoma$

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

$Accelerated hyperfractionation plus temozolomide in glioblastoma$

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma

Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT

KLF6 depletion promotes NF-κB signaling in glioblastoma

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Accelerated hyperfractionation plus temozolomide in glioblastoma

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα

Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness

Related objects

Reset password